EUVIMEDEUVIMED entdecken
Crossref

Recurrent Syncope: Initial Presentation of Transthyretin Amyloidosis. Benefits of Disease-Modifying Treatment

Edileide de Barros Correia, Larissa Ventura Ribeiro Bruscky, Berenice Cataldo Oliveira Valério, Ana Cristina de Souza Murta, Fabiano Castro Albrecht, Ibraim Masciarelli Francisco Pinto, Paola Emanuela Poggio Smanio

ABC: Heart Failure & Cardiomyopathy · 2021

DOI: 10.36660/abchf.20210014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ABC: Heart Failure & Cardiomyopathy, 2021. Verfasst von Edileide de Barros Correia und 6 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Correia, E. D. B., Bruscky, L. V. R., Valério, B. C. O., Murta, A. C. D. S., Albrecht, F. C., Pinto, I. M. F., & Smanio, P. E. P. (2021). Recurrent Syncope: Initial Presentation of Transthyretin Amyloidosis. Benefits of Disease-Modifying Treatment. ABC: Heart Failure & Cardiomyopathy. https://doi.org/10.36660/abchf.20210014

Vancouver

Correia EDB, Bruscky LVR, Valério BCO, Murta ACDS, Albrecht FC, Pinto IMF, et al. Recurrent Syncope: Initial Presentation of Transthyretin Amyloidosis. Benefits of Disease-Modifying Treatment. ABC: Heart Failure & Cardiomyopathy. 2021. doi:10.36660/abchf.20210014

BibTeX
@article{Correia2021,
  author = {Correia, Edileide de Barros and Bruscky, Larissa Ventura Ribeiro and Valério, Berenice Cataldo Oliveira and Murta, Ana Cristina de Souza and Albrecht, Fabiano Castro and Pinto, Ibraim Masciarelli Francisco and Smanio, Paola Emanuela Poggio},
  title = {Recurrent Syncope: Initial Presentation of Transthyretin Amyloidosis. Benefits of Disease-Modifying Treatment},
  journal = {ABC: Heart Failure & Cardiomyopathy},
  year = {2021},
  doi = {10.36660/abchf.20210014}
}
Kostenlos starten →